Clinical Trial Update: Shockwave Coronary Rx Lithoplasty® Study (Disrupt CAD I) [NA]

View source ↗

Summary

Clinical trial update for the Disrupt CAD I study of Shockwave Coronary Lithoplasty in Coronary Artery Disease; status completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Lithoplasty (Shockwave Coronary Lithoplasty)

Snippet

Sponsor: Shockwave Medical, Inc. | Conditions: Coronary Artery Disease | NA | Status: COMPLETED | Results posted: 2018-11-02